Global Pertussis Vaccine Market
Pharmaceuticals

Pertussis Vaccine Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the pertussis vaccine market grown in recent years?

The pertussis vaccine market has grown steadily, increasing from $5.5 billion in 2024 to $5.72 billion in 2025, with a CAGR of 4.1%. The past growth was driven by disease prevalence, immunization programs, pediatric vaccination efforts, and regulatory approvals.

How is the pertussis vaccine market size expected to evolve during the forecast period?

The pertussis vaccine market is projected to grow steadily, reaching $6.62 billion in 2029 with a CAGR of 3.7%. Key growth drivers include increased booster vaccination programs, maternal immunization efforts, healthcare worker immunization, and global health initiatives. Major trends in the market include personalized immunization schedules, combination vaccines, vaccine equity efforts, and the incorporation of digital health in immunization programs.

Get your pertussis vaccine market report here!

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Which key drivers are propelling the pertussis vaccine market’s growth?

The upward trend in childbirth rates is propelling the expansion of the pertussis vaccine market. The process of birthing a child, referred to as childbirth, marks the end of a pregnancy and the start of a new life outside the uterus. The pertussis vaccine, which shields children from whooping cough and other dangerous diseases, is typically administered to children. As an illustration, the Centers for Disease Control and Prevention, a public health organization in the US, reported a 1% increase in registered births in the United States as of January 2023, bringing the total to 3,664,292 births. This upsurge in childbirth rates is fueling the pertussis vaccine market growth.

Pertussis Vaccine Market Driver: Boost in Geriatric Population Numbers Propels Pertussis Vaccine Market Growth

 

What are the market segments in the pertussis vaccine industry?

The pertussis vaccine market covered in this report is segmented –

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine

2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine

3) By Application: Children, Adults, Infants

4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:

1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP

2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

Which leading companies are shaping the growth of the pertussis vaccine market?

Major companies operating in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

What key trends are currently impacting the pertussis vaccine market’s development?

Leading organizations in the pertussis vaccine market are focusing on the development of innovative medicines, securing necessary approvals to maintain their market standing. For example, in October 2022, GSK plc, a renowned UK pharmaceutical and biotechnology firm, announced that the U.S Food and Drug Administration (FDA) had approved BOOSTRIX. This vaccine is a blend of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap). It is designed for use during pregnancy to ward off pertussis, commonly known as whooping cough, in newborn babies. Delivered via a single injection into the upper arm muscle, Boostrix has proven safe and effective for expectant mothers and their infants. Moreover, it offers robust protection against pertussis, including its most severe presentations.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13023

Which geographic areas are influencing the growth of the pertussis vaccine market?

North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Pediatric Vaccine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Cancer Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Meningococcal Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *